Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582257 · ClinicalTrials.gov registry record
Early Onset and Familial Gastric Cancer Registry
A clinical trial of Gastric Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 971
- Enrollment target
- 10
- Study locations
NCT00582257: Completed study of Gastric Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582257 is a study of Gastric Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 971 participants, above the 313-participant average among 153 other Gastric Cancer trials with a reported enrollment target (210% higher). The trial reports 10 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582257, a study of Gastric Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 971 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to establish a gastric cancer registry. A registry is a database of information. With the registry, we can learn more about the genetic causes of gastric cancer in order to develop better methods of early diagnosis, prevention, and treatment of gastric cancers. As part of this study, you will be asked to join a registry of families who are affected with various forms of gastric cancer. These registries are important because they may help physicians better manage gastric cancer now and in the future. Participating in the Early Onset and Familial Gastric Cancer Registry can also be educational for families, since it will provide important information to patients, families, and physicians. All of this will help to further our understanding of genetic causes of gastric cancer and eventually, help determine better ways to diagnose, treat, and survey patients with gastric cancer and people who may have a higher risk for gastric cancer.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires
Study Locations (10)
New York
- Memorial Sloan Kettering Cancer Center at Commack - Commack
- Memorial Sloan Kettering Westchester - East White Plains
- Queens Cancer Center of Queens Hospital - Jamaica
- Memorial Sloan Kettering Cancer Center - New York
- Weill Cornell Medical Center - New York
- Memorial Sloan Kettering Cancer Center at Mercy Medical Center - Rockville Centre
New Jersey
- Memorial Sloan Kettering Cancer Center at Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
California
- University of Southern California - Norris Cancer Hospital - Los Angeles
Other
- Obafemi Awolowo University Teaching Hospital - Ile-Ife
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 971 participants |
| Start Date | 2005-12-13 |
| Est. Completion | 2024-09-30 |
What the finished NCT00582257 record still lists
NCT00582257 is an observational study that tracks outcomes without assigning an intervention. The registered 971 participants enrollment target is mid-sized for trials with a published cap, above the 313-participant average among 153 other Gastric Cancer trials with a reported enrollment target (210% higher).
The record links to 1 condition, with Gastric Cancer appearing as the primary indexed condition, and to 1 intervention - of which questionnaires is the first listed.
NCT00582257 lists 10 locations in 4 states (New York, New Jersey, California).
Frequently Asked Questions
What is clinical trial NCT00582257 about?
NCT00582257 is a clinical study titled "Early Onset and Familial Gastric Cancer Registry". The purpose of this study is to establish a gastric cancer registry. A registry is a database of information. With the registry, we can learn more about the genetic causes of gastric cancer in order to develop better methods of early diagnosis, prevention, and treatment of gastric cancers. As part o...
What is the current status of trial NCT00582257?
This trial is currently completed. The enrollment target is 971 participants. The study started on 2005-12-13. Estimated completion is 2024-09-30.
What conditions does trial NCT00582257 study?
This clinical trial studies the following conditions: Gastric Cancer.
What interventions are being tested in trial NCT00582257?
The interventions under investigation include: questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00582257?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00582257 being conducted?
This trial has 10 study locations across California, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00582257's enrollment target sits among peer trials
971 6th of 153 higher than 148 of 153 other Gastric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
RECRUITING · Phase 1
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05354141 · 970 participants · Phase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- NCT06948422 · 974 participants · Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI